625 related articles for article (PubMed ID: 34480185)
1. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
Izuka S; Yamashita H; Takahashi Y; Kaneko H
Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic Pachymeningitis Development in Eosinophilic Granulomatosis with Polyangiitis at Relapse of Disease: A Case-Based Review.
Kiyohara M; Shirai T; Nishiyama S; Sato H; Fujii H; Ishii T; Harigae H
Tohoku J Exp Med; 2022 Mar; 256(3):241-247. PubMed ID: 35321968
[TBL] [Abstract][Full Text] [Related]
3. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic granulomatosis with polyangiitis.
Romero Gómez C; Hernández Negrín H; Ayala Gutiérrez MDM
Med Clin (Barc); 2023 Apr; 160(7):310-317. PubMed ID: 36774291
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic granulomatosis with polyangiitis.
Villa-Forte A
Postgrad Med; 2023 Jan; 135(sup1):52-60. PubMed ID: 36259957
[TBL] [Abstract][Full Text] [Related]
6. Pathological findings of hypertrophic pachymeningitis associated with eosinophilic granulomatosis with polyangiitis.
Shiraishi W; Tsujimoto Y; Shiraishi T
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34544704
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
Shimojima Y; Sekijima Y
Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
[TBL] [Abstract][Full Text] [Related]
8. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
[TBL] [Abstract][Full Text] [Related]
9. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilic granulomatosis with polyangiitis: A review.
White J; Dubey S
Autoimmun Rev; 2023 Jan; 22(1):103219. PubMed ID: 36283646
[TBL] [Abstract][Full Text] [Related]
11. ANCA-negative ANCA-associated vasculitis: pitfalls of the 'vasculitis screen'.
Cooke H; Wells M; Miller K; Medford ARL; Patel S
Clin Med (Lond); 2023 Nov; 23(6):630-632. PubMed ID: 38065599
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
[TBL] [Abstract][Full Text] [Related]
13. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
Frątczak A; Polak K; Miziołek B; Bergler-Czop B
Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Middle lobe syndrome: a rare presentation in eosinophilic granulomatosis with polyangiitis.
Maranini B; Guzzinati I; Casoni GL; Ballotta M; Lo Monaco A; Govoni M
Front Immunol; 2023; 14():1222431. PubMed ID: 37638004
[TBL] [Abstract][Full Text] [Related]
16. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation.
Gibson LE
Int J Dermatol; 2022 Dec; 61(12):1442-1451. PubMed ID: 35599359
[TBL] [Abstract][Full Text] [Related]
18. [ANCA-associated vasculitis].
Krasselt ML; Holle JU
Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
[TBL] [Abstract][Full Text] [Related]
20. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV.
Sanchez-Alamo B; Schirmer JH; Hellmich B; Jayne D; Monti S; Tomasson G; Luqmani RA
RMD Open; 2023 Jun; 9(2):. PubMed ID: 37349121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]